13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q4 2018. See the latest, Q2 2026 →
Reported value
$399.54B
−16% on the quarter before
Positions
2,029
152 new · 324 sold out
Top 10
15.6%
of the value
Est. gain
−$62.51B
on stocks held all quarter
Est. return
−14.4%
on those stocks since Q3 2018
Positions as of Dec 31, 2018, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 28% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2018. Striped tiles are options.
Largest buys
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$1.39BNew · 0.0% → 0.3%+8,887,937 shares
- Tjx Cos Inc New~$1.11BAdded · 0.8% → 0.7%+24,852,013 shares
- Deere & Co~$1.03BAdded · 0.1% → 0.4%+6,896,669 shares
- Cvs Health Corp~$742.5MAdded · 0.3% → 0.5%+11,331,795 shares
- Bank Amer Corp~$495.5MAdded · 1.2% → 1.3%+20,110,007 shares
- Alphabet~$467.9MAdded · 0.9% → 1.0%+447,806 shares
- Netflix~$466.9MAdded · 0.1% → 0.2%+1,744,486 shares
- Dowdupont Inc~$462.3MAdded · 0.4% → 0.5%+8,644,597 shares
- American Tower~$443.8MAdded · 0.8% → 1.2%+2,805,761 shares
- Home Depot Inc~$430.6MAdded · 0.5% → 0.6%+2,506,287 shares
Largest sells
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Praxair Inc~$1.31BSold out · 0.3% → 0.0%−8,121,107 shares
- Aetna Inc New~$1.05BSold out · 0.2% → 0.0%−5,163,739 shares
- Costco Whsl Corp New~$858.0MCut · 0.5% → 0.3%−4,211,711 shares
- Eli Lilly~$843.3MCut · 1.2% → 1.3%−7,287,411 shares
- Cigna Corporation~$731.1MSold out · 0.2% → 0.0%−3,510,612 shares
- Alphabet~$716.8MCut · 0.6% → 0.4%−692,165 shares
- Broadcom~$694.8MCut · 0.3% → 0.2%−2,732,276 shares
- Microsoft~$668.3MCut · 2.1% → 2.0%−6,580,126 shares
- Apple~$657.0MCut · 0.9% → 0.5%−4,165,159 shares
- Nike Inc~$572.0MCut · 0.7% → 0.6%−7,714,736 shares
Holdings
As of Dec 31, 2018. Changes are in shares against Sep 30, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −7.6% · price −11.2% | 2.0% | $8.10B | −$1.02B | ||||||||
| Unitedhealth Group IncCOM · shares −4.6% · price −6.4% | 1.9% | $7.63B | −$518.2M | ||||||||
| Bristol Myers Squibb CoCOM · shares −4.5% · price −16.3% | 1.8% | $7.03B | −$1.37B | ||||||||
| Verizon Communications IncCOM · shares +6.0% · price +5.3% | 1.8% | $7.01B | +$333.0M | ||||||||
| Medtronic PlcSHS · shares −5.1% · price −7.5% | 1.7% | $6.68B | −$544.2M | ||||||||
| Jpmorgan Chase & CoCOM · shares +0.4% · price −13.5% | 1.4% | $5.66B | −$878.1M | ||||||||
| Eli LillyCOM · shares −14% · price +7.8% | 1.3% | $5.36B | +$389.5M | ||||||||
| Bank Amer CorpCOM · shares +10% · price −16.4% | 1.3% | $5.23B | −$925.8M | ||||||||
| Merck & Co IncCOM · shares −6.9% · price +7.7% | 1.3% | $5.00B | +$357.8M | ||||||||
| Chevron Corp NewCOM · shares −1.5% · price −11.0% | 1.2% | $4.62B | −$572.7M | ||||||||
| American TowerCOM · shares +11% · price +8.9% | 1.2% | $4.62B | +$339.9M | ||||||||
| AlphabetCAP STK CL A · shares +13% · price −13.4% | 1.0% | $4.17B | −$574.6M | ||||||||
| Comcast Corp NewCL A · shares +0.05% · price −3.8% | 1.0% | $4.11B | −$164.2M | ||||||||
| Chubb LimitedCOM · shares +3.2% · price −3.3% | 1.0% | $4.06B | −$135.7M | ||||||||
| Exxon Mobil CorpCOM · shares +10% · price −19.8% | 1.0% | $4.01B | −$897.7M | ||||||||
| AmazonCOM · shares +9.2% · price −25.0% | 0.96% | $3.84B | −$1.17B | ||||||||
| Coca Cola CoCOM · shares +11% · price +2.5% | 0.86% | $3.43B | +$75.7M | ||||||||
| Pnc Finl Svcs Group IncCOM · shares −5.4% · price −14.2% | 0.85% | $3.38B | −$557.5M | ||||||||
| Union Pac CorpCOM · shares −4.4% · price −15.1% | 0.85% | $3.38B | −$600.8M | ||||||||
| Allergan PlcSHS · shares +11% · price −29.8% | 0.83% | $3.33B | −$1.28B | ||||||||
| Pepsico IncCOM · shares +3.8% · price −1.2% | 0.83% | $3.31B | −$38.1M | ||||||||
| Pfizer IncCOM · shares +2.3% · price −1.0% | 0.83% | $3.30B | −$31.0M | ||||||||
| Lockheed Martin CorpCOM · shares +5.7% · price −24.3% | 0.79% | $3.18B | −$965.5M | ||||||||
| CiscoCOM · shares −2.3% · price −10.9% | 0.78% | $3.13B | −$384.2M | ||||||||
| Johnson & JohnsonCOM · shares −0.9% · price −6.6% | 0.77% | $3.09B | −$218.5M | ||||||||
| Total · 2,029 positions | 100% | $399.54B | −$62.51B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2018 to Q4 2018: 1,808 stocks held throughout, down $62.51B (−14.4%).
- Eli Lilly+$389.5M+8%
- Merck & Co Inc+$357.8M+8%
- American Tower+$339.9M+9%
- Verizon Communications Inc+$333.0M+5%
- Encana Corp4:1 split+$226.1M+76%
- Microsoft−$1.02B−11%
- Amazon−$1.17B−25%
- Allergan Plc−$1.28B−30%
- Bristol Myers Squibb Co−$1.37B−16%
- Tjx Cos Inc New−$2.32B−60%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 12 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |